Boiron SA
Research Boiron SA (BOI) on Bullrun: market cap EUR 486.14M, P/E 14.9, dividend yield 4.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBOI
- ExchangePA
- CountryFrance
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 486.14M
- P/E14.9
- Dividend yield4.8%
- Financial periodFY2025
- RevenueEUR 501.11M
- Revenue growth2.8%
- Net incomeEUR 32.64M
- Free cash flowEUR 29.72M
- Gross margin73.0%
Valuation Snapshot
latest market cap is EUR 486.14M; P/E is 14.9; dividend yield is 4.8%.
About Boiron SA
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics, and CBD-based products. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches;
Frequently asked questions
What is Boiron SA's market cap?
Boiron SA's market capitalization is EUR 486.14M.
What is Boiron SA's P/E ratio?
Boiron SA's price-to-earnings (P/E) ratio is 14.9.
Does Boiron SA pay a dividend?
Boiron SA has a dividend yield of 4.8%.
What does Boiron SA do?
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties;